The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment
暂无分享,去创建一个
Bowen Jiang | Xiaochen Qi | Deqian Xie | Dequan Liu | Xiaoxi Wang | Shijin Wang | Jin Wang | Guangzhen Wu
[1] Xinzheng V. Guo,et al. Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. , 2023, Cancer cell.
[2] P. Tassone,et al. Targeting non-coding RNAs: Perspectives and challenges of in-silico approaches. , 2023, European journal of medicinal chemistry.
[3] J. Shih,et al. LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis , 2023, Journal of Biomedical Science.
[4] Jia Liu,et al. Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous cell carcinoma , 2023, Clinical and translational medicine.
[5] Hao Wang,et al. ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer , 2023, Experimental Hematology & Oncology.
[6] Q. Lv,et al. LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1 , 2023, Cancer medicine.
[7] Xiaofeng Yang,et al. Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer , 2023, Cellular Oncology.
[8] K. Jiang,et al. MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2 , 2023, Functional & Integrative Genomics.
[9] Guangzhen Wu,et al. Regulatory roles of ferroptosis-related non-coding RNAs and their research progress in urological malignancies , 2023, Frontiers in Genetics.
[10] F. Chen,et al. Large-scale integration of the non-coding RNAs with DNA methylation in human cancers. , 2023, Cell reports.
[11] Hao Yu,et al. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway , 2023, Journal of Experimental & Clinical Cancer Research.
[12] Hanshao Liu,et al. LncGMDS-AS1 promotes the tumorigenesis of colorectal cancer through HuR-STAT3/Wnt axis , 2023, Cell Death & Disease.
[13] C. Su,et al. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma , 2023, Cancer research.
[14] Dan Xu,et al. Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma , 2023, Cell Death & Disease.
[15] Qi Zhang,et al. Single-cell atlases link macrophages and CD8+ T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma , 2022, Theranostics.
[16] Jingfa Xiao,et al. LncBook 2.0: integrating human long non-coding RNAs with multi-omics annotations , 2022, Nucleic Acids Res..
[17] Matthew D. Young,et al. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer , 2022, Cancer cell.
[18] Jun‐hang Luo,et al. Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma , 2022, Cancer research.
[19] T. Kang,et al. A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers , 2022, Cell Research.
[20] Wancong Zhang,et al. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM , 2022, Frontiers in Immunology.
[21] N. Bolli,et al. Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins , 2022, Haematologica.
[22] J. Pathak,et al. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer , 2022, Journal for ImmunoTherapy of Cancer.
[23] H. Juan,et al. LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1/2 , 2022, Cell Death & Disease.
[24] Xian-lu Song,et al. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling , 2022, Molecular Cancer.
[25] Hui Li,et al. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA–protein ternary complex , 2022, Journal of experimental & clinical cancer research : CR.
[26] Huichuan Sun,et al. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway , 2022, Journal of Experimental & Clinical Cancer Research.
[27] Olaf Johan Hartmann-Johnsen,et al. Subtype and cell type specific expression of lncRNAs provide insight into breast cancer , 2022, Communications Biology.
[28] Wen-Wei Hu,et al. A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3 , 2022, Cell Death & Differentiation.
[29] E. Newell,et al. Single-cell analysis reveals clonally expanded tumor-associated CD57+ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade , 2022, Journal for ImmunoTherapy of Cancer.
[30] Shiyong Xin,et al. Long non-coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway , 2022, International journal of oncology.
[31] Jianzhu Ma,et al. Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma , 2022, Cell Discovery.
[32] Yizhuo Wang,et al. LINC00702-mediated DUSP1 transcription in the prevention of bladder cancer progression: Implications in cancer cell proliferation and tumor inflammatory microenvironment. , 2022, Genomics.
[33] H. Klocker,et al. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer , 2022, Molecular Cancer.
[34] Hong Wu,et al. Long noncoding RNA TLNC1 promotes the growth and metastasis of liver cancer via inhibition of p53 signaling , 2022, Molecular cancer.
[35] Wen Li,et al. Circular RNA Eps15-homology domain-containing protein 2 induce resistance of renal cell carcinoma to sunitinib via microRNA-4731-5p/ABCF2 axis , 2022, Bioengineered.
[36] Shirong Cao,et al. Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis , 2022, Molecular cancer.
[37] Lily Wu,et al. The miRNA-21-5p Payload in Exosomes from M2 Macrophages Drives Tumor Cell Aggression via PTEN/Akt Signaling in Renal Cell Carcinoma , 2022, International journal of molecular sciences.
[38] Guoren Wang,et al. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis , 2022, Laboratory Investigation.
[39] L. Qiao,et al. Single cell RNA-seq analysis identifies a noncoding RNA mediating resistance to sorafenib treatment in HCC , 2022, Molecular Cancer.
[40] Haowen Jiang,et al. Exosome derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironment through modulating reactive oxygen species equilibrium via GLS1 mediated glutamine metabolism alteration. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.
[41] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[42] C. Peano,et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer , 2021, The Journal of experimental medicine.
[43] Zengyue Yang,et al. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway , 2021, Bioengineered.
[44] Mingyao Liu,et al. Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy , 2021, Clinical Cancer Research.
[45] Yunfeng Xu,et al. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1 , 2021, Bioengineered.
[46] F. Demichelis,et al. Circulating RNAs in prostate cancer patients. , 2021, Cancer letters.
[47] Yan Guo,et al. Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial–Mesenchymal Transition in Recurrent Bladder Cancer , 2021, Clinical Cancer Research.
[48] D. Theodorescu,et al. An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer , 2021, Nature Communications.
[49] Shankun Zhao,et al. lncRNA SNHG11 facilitates prostate cancer progression through the upregulation of IGF-1R expression and by sponging miR-184 , 2021, International journal of molecular medicine.
[50] Yang Pan,et al. Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma , 2021, Frontiers in Oncology.
[51] Juze Yang,et al. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC , 2021, Journal of Hematology & Oncology.
[52] Wenquan Zhou,et al. SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155/HIF-1α signaling , 2021, Cell Death & Disease.
[53] Dan Liu,et al. Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling , 2021, Clinical and Translational Oncology.
[54] S. Dhanasekaran,et al. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response , 2021, Proceedings of the National Academy of Sciences.
[55] F. Bray,et al. The ever‐increasing importance of cancer as a leading cause of premature death worldwide , 2021, Cancer.
[56] Yue Li,et al. m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization , 2021, Clinical and translational medicine.
[57] Xinzheng V. Guo,et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages , 2021, Cell.
[58] Jing Zhang,et al. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis , 2021, Drug design, development and therapy.
[59] K. Tomczak,et al. Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing , 2021, Proceedings of the National Academy of Sciences.
[60] Xunbo Jin,et al. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis , 2021, Aging.
[61] C. Leslie,et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. , 2021, Cancer cell.
[62] Xiaolin Zhou,et al. circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis , 2021, Cancer management and research.
[63] R. Wu,et al. Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids , 2021, Advanced science.
[64] Zhiyong Gao,et al. Circular RNA_0000629 Suppresses Bladder Cancer Progression Mediating MicroRNA-1290/CDC73 , 2021, Cancer management and research.
[65] Y. Qiu,et al. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting FOXO3 , 2021, Aging.
[66] G. Shan,et al. CircRNA in cancer: Fundamental mechanism and clinical potential. , 2021, Cancer letters.
[67] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[68] Yali Ji,et al. Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis , 2021, Cancer cell international.
[69] Wei Cheng,et al. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN , 2021, Cellular oncology.
[70] Liang Cheng,et al. Role of microRNA-381 in bladder cancer growth and metastasis with the involvement of BMI1 and the Rho/ROCK axis , 2021, BMC Urology.
[71] Tingting Zhu,et al. Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis , 2021, OncoTargets and therapy.
[72] Yigang Wang,et al. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer , 2021, Bioengineered.
[73] S. Guo,et al. The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis , 2020, Nature Communications.
[74] Xiaokun Zhao,et al. The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization , 2020, Aging.
[75] P. Cao,et al. M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2 , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[76] T. Tang,et al. Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway , 2020, Experimental & Molecular Medicine.
[77] E. Lam,et al. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis , 2020, Molecular Cancer.
[78] Tao Huang,et al. The long non‐coding RNA SNHG1 promotes bladder cancer progression by interacting with miR‐143‐3p and EZH2 , 2020, Journal of cellular and molecular medicine.
[79] Kewei Hu,et al. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression , 2020, Cell Death & Disease.
[80] Maite Huarte,et al. Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion , 2020, The Journal of cell biology.
[81] P. Sun,et al. The FTO/miR‐181b‐3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer , 2020, Cancer Communications.
[82] J. Ji,et al. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway , 2020, Journal of experimental & clinical cancer research : CR.
[83] Yan Cao,et al. LncRNA HOTAIR induces sunitinib resistance in renal cancer by acting as a competing endogenous RNA to regulate autophagy of renal cells , 2020, Cancer Cell International.
[84] Shaowu Zhang,et al. lncRNA_Mdeep: An Alignment-Free Predictor for Distinguishing Long Non-Coding RNAs from Protein-Coding Transcripts by Multimodal Deep Learning , 2020, International journal of molecular sciences.
[85] Zhujuan Wang,et al. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma , 2020, Cell cycle.
[86] P. Carmeliet,et al. Basic and Therapeutic Aspects of Angiogenesis Updated. , 2020, Circulation research.
[87] Ziwei Huang,et al. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma , 2020, Cell Death & Disease.
[88] Chenchen Huang,et al. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR‐515‐5p/GINS2 axis , 2020, Journal of cellular and molecular medicine.
[89] Tianen Wang,et al. A SNP of miR‐146a is involved in bladder cancer relapse by affecting the function of bladder cancer stem cells via the miR‐146a signallings , 2020, Journal of cellular and molecular medicine.
[90] C. Bettegowda,et al. The long non-coding RNA lnc-HLX-2-7 is oncogenic in group 3 medulloblastomas , 2020, bioRxiv.
[91] Chun Jimmie Ye,et al. Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer , 2020, Cell.
[92] Jian Wang,et al. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma , 2020, Cell cycle.
[93] S. Markovic,et al. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy , 2020, Journal of experimental & clinical cancer research : CR.
[94] Ninghan Feng,et al. Tumor‐associated macrophages promote prostate cancer progression via exosome‐mediated miR‐95 transfer , 2020, Journal of cellular physiology.
[95] Hongyan Liu,et al. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539 , 2020, Cell cycle.
[96] P. Marchetti,et al. The T1D-associated lncRNA Lnc13 modulates human pancreatic β cell inflammation by allele-specific stabilization of STAT1 mRNA , 2020, Proceedings of the National Academy of Sciences.
[97] Deepali V. Sawant,et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer , 2020, Cell.
[98] M. Zheng,et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST , 2020, Molecular Cancer.
[99] Rui Wei,et al. Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers , 2020, Analytical cellular pathology.
[100] L. Hua,et al. MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression , 2019, Journal of cellular and molecular medicine.
[101] X. Gou,et al. Bladder cancer cell-secreted exosomal miR-21 activates the PI3K/AKT pathway in macrophages to promote cancer progression , 2019, International journal of oncology.
[102] Z. Ouyang,et al. CircRNA hsa_circ_0074834 promotes the osteogenesis-angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by acting as a ceRNA for miR-942-5p , 2019, Cell Death & Disease.
[103] Y. Zuo,et al. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[104] Hao Wu,et al. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway , 2019, Journal of Experimental & Clinical Cancer Research.
[105] Ya-bin Liu,et al. LncRNA LOXL1‐AS1/miR‐let‐7a‐5p/EGFR‐related pathway regulates the doxorubicin resistance of prostate cancer DU‐145 cells , 2019, IUBMB life.
[106] Xianwen Ren,et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma , 2019, Cell.
[107] Li Zhao,et al. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis , 2019, Journal of Hematology & Oncology.
[108] Yue Wang,et al. The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7. , 2019, European urology.
[109] Siwei Wang,et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy , 2019, Journal of Hematology & Oncology.
[110] M. Spahn,et al. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo , 2019, BMC Cancer.
[111] Zekuan Xu,et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway , 2019, Molecular Cancer.
[112] A. R. Fernandes,et al. Targeting Tumor Microenvironment for Cancer Therapy , 2019, International journal of molecular sciences.
[113] Yi-jun Shen,et al. circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762. , 2019, Oncology letters.
[114] A. Mele,et al. Mapping of In Vivo RNA-Binding Sites by Ultraviolet (UV)-Cross-Linking Immunoprecipitation (CLIP). , 2018, Cold Spring Harbor protocols.
[115] Xiang-Nan Li,et al. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer , 2018, Journal of Experimental & Clinical Cancer Research.
[116] S. Volinia,et al. SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies? , 2018, High-throughput.
[117] Wei Wang,et al. LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA‐135a binding site affects bladder cancer risk , 2018, International journal of cancer.
[118] Gong Zhang,et al. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma , 2018, Nature Communications.
[119] E. Zhang,et al. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1 , 2018, Genome Biology.
[120] Kejing Wu,et al. MicroRNA-transcription factor network analysis reveals miRNAs cooperatively suppress RORA in oral squamous cell carcinoma , 2018, Oncogenesis.
[121] J. T. Afshari,et al. Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.
[122] Ye Liu,et al. Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway. , 2018, International journal of molecular medicine.
[123] J. Ule,et al. The Future of Cross-Linking and Immunoprecipitation (CLIP). , 2018, Cold Spring Harbor perspectives in biology.
[124] M. Lai,et al. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68 , 2018, Molecular Cancer.
[125] P. Boutros,et al. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19 , 2018, Cell.
[126] R. Weinberg,et al. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities , 2018, Frontiers of Medicine.
[127] D. Beer,et al. Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer. , 2018, Cancer research.
[128] May D. Wang,et al. LncADeep: an ab initio lncRNA identification and functional annotation tool based on deep learning , 2018, Bioinform..
[129] Xing Luo,et al. Long Non-Coding RNA Emergence During Renal Cell Carcinoma Tumorigenesis , 2018, Cellular Physiology and Biochemistry.
[130] E. Giovannetti,et al. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression , 2018, Nature Communications.
[131] Yuan Chang,et al. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment , 2018, Molecular Cancer.
[132] R. Weinberg,et al. Understanding the tumor immune microenvironment (TIME) for effective therapy , 2018, Nature Medicine.
[133] Michael B. Stadler,et al. Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells , 2018, Cell Death & Differentiation.
[134] Yanda Lu,et al. LncRNA FUNDC2P4 down-regulation promotes epithelial–mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation , 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[135] G. Pintacuda,et al. Function by Structure: Spotlights on Xist Long Non-coding RNA , 2017, Front. Mol. Biosci..
[136] Yan Zhou,et al. miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells. , 2017, Cancer research.
[137] Mian Wu,et al. LAST, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote CCND1 mRNA stability in human cells , 2017, eLife.
[138] Yuan Zhang,et al. Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity , 2017, International journal of biological sciences.
[139] Y. Mo,et al. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer , 2017, Molecular Cancer.
[140] T. Cech,et al. How do lncRNAs regulate transcription? , 2017, Science Advances.
[141] Wei Chen,et al. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1 , 2017, Molecular Cancer.
[142] Hui Zhang,et al. LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma , 2017, Oncotarget.
[143] J. Rinn,et al. Neat1 is a p53-inducible lincRNA essential for transformation suppression , 2017, Genes & development.
[144] Li-Yuan Xie,et al. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma , 2017, BMC Cancer.
[145] Michael B. Stadler,et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma , 2017, Cell.
[146] Laising Yen,et al. Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis. , 2017, Cancer research.
[147] N. Rajewsky,et al. Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis , 2017, Molecular cell.
[148] N. Hacohen,et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors , 2017, Science.
[149] J. Wargo,et al. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.
[150] Alberto Mantovani,et al. Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.
[151] Y. Liu,et al. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition , 2016, Oncotarget.
[152] E. Zhang,et al. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma , 2016, Nucleic acids research.
[153] Dorota H. Sendorek,et al. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer , 2016, Nature Genetics.
[154] K. D. Sørensen,et al. The Potential of MicroRNAs as Prostate Cancer Biomarkers. , 2016, European urology.
[155] Wei Chen,et al. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC , 2016, Journal of Experimental & Clinical Cancer Research.
[156] Jin Ding,et al. Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. , 2016, Cancer cell.
[157] P. Pandolfi,et al. Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations , 2016, Cell.
[158] G. Bhagat,et al. A long noncoding RNA associated with susceptibility to celiac disease , 2016, Science.
[159] A. Hofman,et al. Refined mapping of autoimmune disease associated genetic variants with gene expression suggests an important role for non-coding RNAs , 2016, Journal of autoimmunity.
[160] O. Pardo,et al. miR‐515‐5p controls cancer cell migration through MARK4 regulation , 2016, EMBO reports.
[161] Jie Wu,et al. deepBase v2.0: identification, expression, evolution and function of small RNAs, LncRNAs and circular RNAs from deep-sequencing data , 2015, Nucleic Acids Res..
[162] Jia Meng,et al. lncRScan-SVM: A Tool for Predicting Long Non-Coding RNAs Using Support Vector Machine , 2015, PloS one.
[163] Lan Shen,et al. TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT , 2015, Scientific Reports.
[164] C. Croce,et al. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. , 2015, Journal of the National Cancer Institute.
[165] S. Linnarsson,et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq , 2015, Science.
[166] V. Weaver,et al. The extracellular matrix modulates the hallmarks of cancer , 2014, EMBO reports.
[167] R. Parker,et al. Circular RNAs: diversity of form and function , 2014, RNA.
[168] Kotb Abdelmohsen,et al. Functional interactions among microRNAs and long noncoding RNAs. , 2014, Seminars in cell & developmental biology.
[169] Anindya Dutta,et al. Long non-coding RNAs as emerging regulators of differentiation, development, and disease , 2014, Transcription.
[170] M. Weng,et al. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer , 2014, Molecular Cancer.
[171] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[172] Junhui Ge,et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus , 2014, Cell Research.
[173] M. Todaro,et al. Tumor and its microenvironment: a synergistic interplay. , 2013, Seminars in cancer biology.
[174] B. Andersen,et al. Informal caregiving for cancer patients , 2013, Cancer.
[175] Jeannie T. Lee,et al. Long Noncoding RNAs: Past, Present, and Future , 2013, Genetics.
[176] Sebastian D. Mackowiak,et al. Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.
[177] T. Hagemann,et al. The tumor microenvironment at a glance , 2012, Journal of Cell Science.
[178] David G. Knowles,et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.
[179] Raymond K. Auerbach,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[180] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[181] O. Slabý,et al. Novel classes of non-coding RNAs and cancer , 2012, Journal of Translational Medicine.
[182] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[183] D. Cacchiarelli,et al. A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.
[184] Howard Y. Chang,et al. Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.
[185] V. Kataja,et al. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[186] John T. Wei,et al. Transcriptome Sequencing Identifies PCAT-1, a Novel lincRNA Implicated in Prostate Cancer Progression , 2011, Nature biotechnology.
[187] C. Glass,et al. Non-coding RNAs as regulators of gene expression and epigenetics. , 2011, Cardiovascular research.
[188] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[189] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[190] T. Derrien,et al. Long Noncoding RNAs with Enhancer-like Function in Human Cells , 2010, Cell.
[191] M. Shike,et al. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. , 2010, Gastroenterology.
[192] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[193] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[194] G. Berx,et al. Involvement of members of the cadherin superfamily in cancer. , 2009, Cold Spring Harbor perspectives in biology.
[195] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[196] R. Hynes. The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.
[197] D. Spector,et al. Long noncoding RNAs: functional surprises from the RNA world. , 2009, Genes & development.
[198] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[199] Anindya Dutta,et al. MicroRNAs in cancer. , 2009, Annual review of pathology.
[200] L. Kiemeney,et al. Polymorphisms in the H19 gene and the risk of bladder cancer. , 2008, European urology.
[201] A. Gabory,et al. The H19 locus acts in vivo as a tumor suppressor , 2008, Proceedings of the National Academy of Sciences.
[202] Charles Lee,et al. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders , 2007, Nature Genetics.
[203] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[204] Mariette Schrier,et al. A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.
[205] C. Burge,et al. The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.
[206] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[207] K. Kosik,et al. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.
[208] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[209] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[210] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[211] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[212] Michael Thomas,et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.
[213] M. Augustus,et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[214] S. Niture,et al. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation. , 2022, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[215] OUP accepted manuscript , 2021, Briefings In Bioinformatics.
[216] J. Cai,et al. HOTAIR: a cancer-related long non-coding RNA. , 2014, Neoplasma.